Globus Medical (GMED) Current Deferred Revenue (2017 - 2026)

Globus Medical (GMED) has reported Current Deferred Revenue for 10 consecutive years, with $36.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue rose 50.29% year-over-year to $36.1 million; the trailing twelve-month figure through Jun 2026 stood at $36.1 million (up 50.29% YoY), and the FY2025 full-year result was $36.9 million, up 16.05% from the prior year.
• Current Deferred Revenue advanced to $36.1 million in Q2 2026 per GMED's latest filing, from $34.9 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $36.9 million in Q4 2025 and bottomed at $11.8 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $20.7 million across 5 years, with a median of $18.1 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue decreased 12.19% in 2025, then surged 103.24% in 2026.
• Over 5 years, Current Deferred Revenue stood at $14.1 million in 2022, then soared by 30.28% to $18.4 million in 2023, then soared by 73.17% to $31.8 million in 2024, then rose by 16.05% to $36.9 million in 2025, then decreased by 2.21% to $36.1 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $36.1 million, $34.9 million, and $36.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.